Cancer Care Portal | Latest News, Research, and Support

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

News

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Editor - February 11, 2026

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

News

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Editor - February 11, 2026

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

Vital Information

News

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

News

MRD Testing Could Supply Peace of Thoughts to Breast Most cancers Survivors

News

A Household’s Power Via Liver Most cancers and Residing Donation

News

Why Subcutaneous Darzalex Faspro Issues for Sufferers With A number of Myeloma

News

From Missed Indicators to Second Possibilities After a Liver Most cancers Prognosis

Editor - February 10, 2026

Keytruda Combo Accredited for Platinum-Resistant Ovarian Most cancers

Editor - February 10, 2026

Chris Draft Shares Steps to Assist Sufferers Regain Management After Most cancers

Editor - February 10, 2026

FDA Quick Observe Designation Highlights New Possibility in Superior Liver Most cancers

Editor - February 10, 2026

In search of a Dose of Hope Amidst Most cancers

Editor - February 10, 2026

FDA Clears Part 2b Research of Teverelix in Superior Prostate Most cancers

Editor - February 10, 2026

When Most cancers Care Turns into a Logistical Balancing Act

Facts

Research Hyperlinks Drug Remedy to Fewer Sizzling Flashes Throughout Prostate Most cancers Care

February 9, 2026

Why Breast Most cancers Care Is not One Measurement Matches All

February 9, 2026

Mother of 4 Shares Story of Her Breast Most cancers Prognosis

February 9, 2026

Most cancers Anniversaries Good and Unhealthy

February 9, 2026

A Liver Most cancers Journey Marked by Persistence, Household and Hope

February 9, 2026

FDA Grants Designation to Immunotherapy KB707 for Superior NSCLC

February 9, 2026

Latest Articles

News

Tukysa Makes Waves as Firstline Upkeep in HER2+ Breast Most cancers

Editor - January 10, 2026

Wrapping up what she described as a “blockbuster 12 months” for developments in breast most cancers remedy analysis, Dr. Erika Hamilton sat...

News

The Price of Surviving Most cancers

Editor - January 10, 2026

When most individuals take into consideration most cancers, they give thought to survival. What they don’t usually take into account is what...

News

Prime 5 Genitourinary Most cancers Tales of 2025: Analysis, Remedies and Care

Editor - January 10, 2026

Sufferers with genitourinary cancers had a number of advances in care, analysis and assets in 2025. From new therapy choices to instruments...

News

Breaking Down Facet Results of Tukysa in HER2+ Breast Most cancers

Editor - January 10, 2026

Dr. Erika Hamilton not too long ago mentioned her work on the HER2CLIMB05 medical trial evaluating Tukysa (tucatinib) together with Herceptin (trastuzumab)...

News

Grateful Coronary heart: Gratitude for Assist By way of Most cancers and Loss

Editor - January 10, 2026

As most who've been by means of or are at present going by means of most cancers know, most cancers generally is...

1...353637...1,671 Page 36 of 1,671

The Cancer

Don't Miss

Vital Information

Facts

Latest Articles

Hot Topics

Quick Links

Must Read

Popular Articles